Vantage logo

Spybiotech seeks new vaccines

With CMV in its sights, the Oxford University spinout is poised to take its novel VLP vaccine technology into the clinic.

Vantage logo

Novocure aims to plough a new field

Lung cancer approval for the group’s electric fields-based therapy could come this year, but Novocure has broader solid tumour ambitions.

Vantage logo

Astrazeneca gets personal

A collaboration this week with the blood testing specialist Capitainer underlines the big pharma’s ambition to have a diagnostic linked with every pipeline project.